The concept of medical beauty is a popular track that has attracted a lot of attention recently, but many stock investors don’t know what the medical beauty concept stocks are. Today, Financial Manager has sorted out a list of leading medical beauty concept stocks for investors. refer to.
Jindawei (002626)
The main business of Xiamen Jindawei (002626) Group Co., Ltd. is the production of nutritional and health food raw materials, pharmaceutical raw materials and nutritional and health food terminal products and sales operations. The company's main products include coenzyme Q10 series, vitamin A series, vitamin D3 series, vitamin K2 series, microalgae DHA, plant-based ARA, etc. The company and its wholly-owned subsidiaries have obtained 9 patent certificates (7 invention patents and 2 utility model patents).
Huadong Medicine (000963)
Huadong Medicine (000963) Co., Ltd.’s main business covers the entire pharmaceutical industry chain, with the pharmaceutical industry as the leading industry, while also expanding the pharmaceutical business and medical aesthetics industry , integrating pharmaceutical research and development, production and distribution. The medical beauty industry focuses on the R&D, production and sales of non-surgical mainstream medical beauty products such as facial fillers, body shaping, thread embedding, and energy source devices. The company's main products include Western and Chinese medicines, medical devices, differentiated sodium hyaluronate full product portfolio, collagen stimulators, botulinum toxin type A, implantation lines, energy source equipment, etc. The company's two microbial drugs, cyclosporine and acarbose, both won the second prize of the National Science and Technology Progress Award. The company's pharmaceutical business is one of the top and most powerful comprehensive large-scale pharmaceutical industry service providers in Zhejiang Province.
Huilong Co., Ltd. (002556)
The main business of Anhui Huilong Agricultural Materials Group Co., Ltd. is the domestic and foreign trade distribution business of fertilizers, chemicals and pesticide products. The company’s main products include nitrogen fertilizers , potassium fertilizer and compound fertilizer. The company is an advocate of chain operation of agricultural supplies in China, pioneered the listing of agricultural supplies circulation enterprises in the national supply and marketing cooperative system, and is the leader and practitioner of "China's modern agricultural comprehensive service provider". The comprehensive competitiveness of the industry ranks fourth in the country and won the Honorary titles such as "Outstanding Contribution Award for the 20th Anniversary of China's Fertilizer Circulation System Reform", "No. 487 of Fortune China's Top 500", and "China's Famous Trademark".
Fujilai (301258)
Suzhou Fujilai Pharmaceutical Co., Ltd. is mainly engaged in the research, development, production and sales of pharmaceutical intermediates, APIs and health care raw materials. Its main products include lipoic acid series, phosphatidylcholine series and carnosine series. The company has won honors such as the Suzhou Science and Technology Progress Award, the second prize of the Shanghai Science and Technology Progress Award, and the first prize of the Shanghai Science and Technology Progress Award.
Xinhua Pharmaceutical (000756)(000756)
Shandong Xinhua Pharmaceutical Co., Ltd. is mainly engaged in the development, manufacturing and sales of chemical raw materials, preparations and chemical products; the company’s main products are solutions Thermal analgesic APIs, tablets, injections, capsules, and pharmaceutical intermediates. The company has advantages in technological innovation and is now a high-tech enterprise, a key high-tech enterprise in the National Torch Plan, and a key enterprise in the biomedical industry base of the National Torch Plan. It has a national-level enterprise technology center and a corporate postdoctoral research station. "Construction and scale development of caffeine green preparation system based on key industrial technologies" won the second prize of the 2018 Shandong Province Science and Technology Progress Award. In the first half of the year, 10 patents were authorized. The company was announced as a "Technological Innovation Demonstration Enterprise in Shandong Province" and was rated as an advanced unit for talent work in Shandong.
Lafang Jiahua (603630)(603630)
Lafang Jiahua Co., Ltd. is mainly engaged in the research and development, production and sales of washing and care products, skin care products, and makeup products. During the reporting period, the company continued to carry out product innovation, brand category matrix construction, and marketing channel network updates and upgrades. The main products include cream, conditioner, shower gel, shampoo, soap, gel water, and gel cream.
Aier Eye Hospital (300015)(300015)
Aier Eye Hospital Group Co., Ltd. is an ophthalmic medical institution. The company is mainly engaged in the diagnosis and treatment of various eye diseases, surgical services and medicine. Optometry and glasses. The company hosted academic conferences such as the 2019 International Retina Summit Forum, the International Refractive Forum, and the Smart Medical Summit Forum, released the "AIER Ophthalmology Big Data Report on Chinese Fundus Disease Status", and successfully won the sponsorship of the 19th World Myopia Conference in 2023. right.
Langzi Co., Ltd. (002612)(002612)
Langzi Co., Ltd. is a pure women's clothing company dedicated to the high-end women's clothing market. Its main business is the design of branded women's clothing, Production and sales. The company's three core brands include its own brands "Langzi" and "Rhine", as well as the "Zhuoke" series of brands that are exclusively authorized in China; its main products and services include women's tops, women's pants, women's skirts, Women's outerwear, baby clothing, baby products, surgical medical cosmetology, non-surgical medical cosmetology, and consulting services. The company has obtained 2 national invention patents, 30 software copyrights, 12 design patents, and 13 utility model patents.
Taiji Group (600129)(600129)
Chongqing Taiji Industrial (600667) (Group) Co., Ltd. is mainly engaged in the production and sales of Chinese and Western patent medicines. The company's main products are Huoxiang Zhengqi Oral Liquid, Ceftizoxime Sodium for Injection (Eboschlin), Lofencodeine Sustained Release Tablets (Siweipu), Xiaojin Tablets, and Morphine Hydrochloride Sustained Release Tablets (Mephicon). , Rosiglitazone Sodium Tablets (Tero), Jizhizhi Syrup, Compound Isatis Granules, Tongtian Oral Liquid, Sodium Chloride Injection, Sinusitis Oral Liquid, Liuwei Dihuang Pills, Xuanmai Ganju Granules, Agarwood Huaqi Tablets, Tian Glue, Glucose Injection, Hashtong, Digestive Enzyme Tablets, Metoprolol Tartrate Sustained Release Tablets, Xia Sangju Granules, Ganmao Qingre Granules, Wuzi Yanzong Pills. The company is one of the large-scale enterprise groups with the most complete domestic pharmaceutical industry chain. "TAIJI" is one of the first batch of well-known trademarks in China, and ranks first among OTC brand pharmaceutical companies; "Tongjunge" is a century-old brand, and Tongjunge's traditional pill making techniques have been included in the country's "intangible cultural heritage...
Yunnan Baiyao (000538) Group Co., Ltd. is a company mainly engaged in chemical raw materials, chemical preparations, Chinese patent medicines, Chinese medicinal materials, biological products, etc. The company's products include Yunnan Baiyao series, Panax notoginseng series and Yunnan Baiyao series. Mainly specializing in ethnic medicine series, there are more than 200 products in 17 dosage forms. The products sell well in the domestic market and Southeast Asia, and have gradually entered the markets of developed countries such as Japan, Europe and the United States. The company is one of the well-known Chinese patent medicine manufacturers in Yunnan. One of the largest industrial and commercial pharmaceutical companies, it is one of the top 50 Chinese patent medicine companies. In 1997, it was identified as one of the first forty major enterprise groups to be cultivated in Yunnan Province. The 2010 Traditional Chinese Medicine Industry Brand Summit Brand Selection Event was first released. On the list of the top ten corporate brands in various fields of the traditional Chinese medicine industry, Yunnan Baiyao ranked first among the top ten traditional brands of traditional Chinese medicine companies. In September 2017, Yunnan Baiyao was selected into the "2016. ..